戻る Agenda
PV.S4. – Pharmacovigilance New Horizons
Session Chair(s)
Manny (Manish) Soman
CEO
Wipro Life Science Solutions, India
As the scope of PV expands beyond traditional pharmaceuticals, this session explores emerging frontiers reshaping the safety landscape. Experts will discuss the growing importance of pharmacovigilance for OTC products and nutraceuticals, examining regulatory expectations, risk profiles, and how safety strategies differ from prescription medicines. The session will also delve into innovations in signal detection and management, highlighting the integration of advanced analytics and automation to improve proactivity and precision. Finally, attendees will gain insights into the increasing role of social media monitoring and local literature surveillance in identifying safety signals, along with the operational and compliance challenges these unconventional sources present. This session aims to equip PV professionals with the foresight and tools needed to navigate the evolving safety paradigm.
Speaker(s)
Having A Re-Look at Vaccine Safety & its Epidemiological Impact
Raghavendra Pai
Takeda, Singapore
Head of PV, SEA
Innovation & Signal Management Perspective
Pranav Sikka
Novartis, India
Global Head Safety Detection and MQM
Growing Importance of Social Media Monitoring And Its Challenges in PV And Local Literature Surveillance
Abdul Rahim
ALWIS Solutions Ltd, India
Director